Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

@article{Alhazzani2020SurvivingSC,
  title={Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)},
  author={Waleed Alhazzani and Morten Hylander M{\o}ller and Yaseen M. Arabi and Mark Loeb and Michelle Ng Gong and Eddy Fan and Simon J. W. Oczkowski and Mitchell M. Levy and Lennie P. G. Derde and Amy L. Dzierba and Bin Du and Michael S. Aboodi and Hannah Wunsch and Maurizio Cecconi and Younsuck Koh and Daniel S. Chertow and Kathryn Maitland and Fayez Ebrahim Alshamsi and Emilie P. Belley‐Cote and Massimiliano Greco and Matthew Laundy and Jill S Morgan and Jozef Kesecioglu and Allison McGeer and Leonard A. Mermel and Manoj J. Mammen and Paul El{\'i}as Alexander and Amy S. Arrington and John E. Centofanti and Giuseppe Citerio and Bandar Baw and Ziad A. Memish and Naomi E. Hammond and Frederick G. Hayden and Laura Evans and Andrew Rhodes},
  journal={Intensive Care Medicine},
  year={2020},
  volume={46},
  pages={854 - 887}
}
Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed. Methods We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant… 
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
TLDR
The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued several recommendations to guide healthcare professionals caring for adults with critical or severe coronavirus disease 2019 in the ICU, and based on a living guideline model the recommendations will be updated as new evidence becomes available.
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection
TLDR
The rapidly expanding literature around the pathophysiology, clinical presentation, and management of COVID-19 is synthesized with a focus on those points most relevant for intensivists tasked with caring for patients infected with SARS-CoV-2.
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
TLDR
Front-line experts in China fighting against the COVID-19 epidemic in Wuhan were organized to develop an expert statement to provide trustworthy recommendation on the management of critically ill CO VID-19 patients, with a strong agreement from voting participants.
Medical Management of COVID-19: Evidence and Experience
TLDR
This review article seeks to collate and provide a summary of treatment strategies for COVID-19 patients with a variable degree of illness and discuss pharmacologic and other therapies intended to be used either as experimental medicine/therapy or as part of supportive care in complicated cases of CO VID-19.
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Clinical phenotypes of critically ill COVID-19 patients
TLDR
Clinical and laboratory features in an observational cohort of 85 consecutive COVID-19 patients admitted to an ICU in Paris, France, between March 7 and April 6, 2020 are reported.
How the Covid-19 epidemic is challenging our practice in clinical nutrition—feedback from the field
TLDR
A flow chart for optimizing the nutrition management of the Covid-19 patients in the non-ICU wards is proposed and ten challenges for clinical nutrition practice are emphasized.
Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients
TLDR
Treatment of critically ill COVID-19 patients is protracted and resource-intense, and in a context without resources shortage, 50% of CO VID-19 with respiratory failure survived up to 60 days.
...
...

References

SHOWING 1-10 OF 354 REFERENCES
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.
TLDR
The WHO interim guidelines made general recommendations for treatment of ARDS in this setting, including that consideration be given to referring patients with refractory hypoxemia to expert centers capable of providing extracorporeal membrane oxygenation (ECMO).
Coronavirus Disease 2019 (COVID-19): A Brief Report
TLDR
Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough, and bilateral lung involvement with ground-glass opacities is themost common finding from computed tomography (CT) images of the chest.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
TLDR
Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
Critical care management of adults with community-acquired severe respiratory viral infection
TLDR
Limited existing knowledge highlights the need for data regarding supportive care and adjunctive pharmacologic therapy that is specific for critically ill patients with severe RVI, and there is a need for more pragmatic and efficient designs to test different therapeutics both individually and in combination.
SARS: Systematic Review of Treatment Effects
TLDR
It was not possible to determine whether treatments benefited patients during the SARS outbreak, but clinical trials should be designed to validate a standard protocol for dosage and timing and to accrue data in real time during future outbreaks to monitor specific adverse effects and help inform treatment.
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012
TLDR
An update to the “Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock,” last published in 2008 is provided.
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
TLDR
Corticosteroid therapy in patients with MERS was not associated with a difference in mortality after adjustment for time‐varying confounders but was associated with delayed MERS coronavirus RNA clearance.
...
...